{{Rsnum
|rsid=10483853
|Gene=NUMB
|Chromosome=14
|position=73289591
|Orientation=minus
|GMAF=0.3545
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NUMB
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 24.1 | 73.2
| HCB | 39.4 | 46.7 | 13.9
| JPT | 53.6 | 39.3 | 7.1
| YRI | 5.4 | 34.0 | 60.5
| ASW | 12.3 | 33.3 | 54.4
| CHB | 39.4 | 46.7 | 13.9
| CHD | 42.2 | 45.9 | 11.9
| GIH | 5.9 | 21.8 | 72.3
| LWK | 10.9 | 40.0 | 49.1
| MEX | 10.3 | 51.7 | 37.9
| MKK | 10.9 | 39.1 | 50.0
| TSI | 3.9 | 35.3 | 60.8
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs10483853
|PubMedID=17903303
|Condition=Coronary artery calcification
|Gene=NUMB
|Risk Allele=
|pValue=6.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs10483853
|Name_s=
|Gene_s=NUMB
|Feature=
|Evidence=PubMed ID:17903303; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study (Initial Sample Size: 673-984 individuals, depending on measure (Framingham); Replication Sample Size: NR). This variant is associated with Coronary artery calcification.
|Drugs=
|Drug Classes=
|Diseases=Arteriosclerosis; Cardiovascular Diseases; Coronary Disease
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356501
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10483853
|overall_frequency_n=47
|overall_frequency_d=128
|overall_frequency=0.367188
|n_genomes=33
|n_genomes_annotated=0
|n_haplomes=41
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}